SenesTech Remains Undervalued

SenesTech develops, manufacturers, and distributes non-toxic rodent birth control used to eradicate rodent infestations. The company is experiencing rapid growth and increasing revenues with its innovative products. I rate the company as a Buy.

Image Source: Grok AI
 

SenesTech’s urban deployments are shaping up to be a game-changing inflection point for the company — and potentially the entire pest control industry. With municipal adoption now underway in four of America’s most rat-infested cities, SenesTech is no longer just selling a product, it’s embedding itself into the long-term infrastructure of public health and urban sanitation that is government funded.

SenesTech (SNES) has recently released two new products in the market with great success. The company reported its Q51-202 results last month and showed increasing revenues YoY. SenesTech has a large and growing domestic and international distribution footprint for its bait. Revenues will continue to increase over the next physical year or two.

This post has been upgraded to a full article. Read it for free here.


Related Articles:
SenesTech's Big Play On Small Pests
SenesTech CEO Reveals Surprise San Francisco Expansion
SenesTech: A Little-Known Biotech Company Worthy Of Attention
SenesTech: The Smart Money’s Bet On Rodent Population Control
SenesTech Has Built A Better Mouse Trap

More By This Author:
AXT, Inc. Positioned For Growth From Increase In AI Computing
Enveric Biosciences Rallies 300% As It Receives US Patents For Psychedelic Compounds
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

STOCKS IN THIS BLOG POST

Also Mentions:

Comments